Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OVERBY, H. T.
Right arrow Articles by WOLIUNG, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OVERBY, H. T.
Right arrow Articles by WOLIUNG, R. W.
(Chest. 1955;27:51-58.)
© 1955 American College of Chest Physicians

Experiences in the Management of Long-Standing Chronic Cases of Pulmonary Tuberculosis Treated with Isoniazid for One Year

HARRY T. OVERBY M.D.1 and ROBERT W. WOLIUNG M.D.1

1 Dunham Hospital of Hamilton County (Tuberculosis), (a Subdepartment in the Department of Medicine, College of Medicine, University of Cincinnati)

1. Thirty-eight "maximum benefit" or "good chronic" cases of pulmonary tuberculosis considered therapeutic failures to streptomycin and para-aminosalicylic acid, when treated with isoniazid alone for one year showed a promising clinical response.

2. Marked improvement in subjective symptoms such as morale and sense of well-being were noted from the onset of therapy. Improvement of appetite and weight gain were marked. Cough reduction and sputum volume reduction were striking. A sharp reduction in consumption of cough medicine paralleled the finding of cough and sputum reduction.

3. X-ray shadow improvement did not parallel clinical bettering. However, definite roentgenologic improvement was demonstrable, and after one year, six patients, heretofore considered to have poor prognosis for cure, were discharged from the hospital as arrested, with negative sputum.

4. An appreciable reduction in positive sputa was observed soon after institution of therapy. After one month of therapy the number with positive sputum decreased from 36 to nine. At any given time during the study the incidence of positive sputa among these patients was less than 50 per cent, whereas prior to therapy over 94 per cent were positive.

5. Isoniazid alone may have therapeutic efficacy in the management of "maximum benefit" or "good chronic" cases upon whom other therapeutic regimens have failed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1955 by the American College of Chest Physicians.